Every 10-Q that Virnetx Holding (VHC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow VHC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VHC filings page.
VirnetX Holding Corporation reported continued operating losses and liquidity pressure for the quarter ended June 30, 2026. Revenue was $0 for both the three- and six-month periods, compared with $48,000 a year earlier, while operating expenses rose to $4.7 million in the quarter, driven mainly by higher selling, general and administrative costs.
Net loss was $4.5 million for the quarter and $8.9 million for the first half of 2026, increasing from $7.3 million in the prior-year six-month period. Cash and cash equivalents fell to $13.1 million from $15.5 million at year-end, with $7.6 million used in operating activities in the first half.
Total assets were $23.0 million and shareholders’ equity $15.1 million, against total liabilities of $7.9 million. Management concluded that existing liquidity is insufficient to fund operations for 12 months without additional revenue or capital, leading to a going concern warning. The company highlights a $20 million effective shelf registration and continues to focus on commercializing its VirnetX One™, Matrix™, War Room™ and iSCOUT cybersecurity platforms, particularly for U.S. defense, government and critical infrastructure customers.
VirnetX Holding Corporation reported a net loss of $4.4 million for the quarter ended March 31, 2026, with no revenue, compared with a $3.7 million loss a year earlier. Operating expenses were $4.5 million, driven by research and development and higher selling, general and administrative costs. Cash, cash equivalents and short‑term investments totaled about $17.2 million, and total assets were $26.7 million against shareholders’ equity of $18.9 million. Management states there is substantial doubt about the company’s ability to continue as a going concern, as current liquidity is projected to be insufficient to fund operations for twelve months without additional revenue or capital, likely through equity offerings.
VirnetX Holding Corporation reported results for the quarter ended June 30, 2025, showing continued operating losses while maintaining a multi-month cash runway. Revenue was immaterial at $48 thousand for the six months ended June 30, 2025. Operating expenses totaled $8.0 million for the six months, driven by $2.47 million in R&D and $5.57 million in selling, general and administrative expenses.
The company recorded a six-month net loss of $7.3 million (basic loss per share $1.99), and used $6.8 million of cash in operating activities during the period. At June 30, 2025, VirnetX held $17.3 million in cash and $13.9 million of investments available for sale, totaling $31.2 million in liquid resources. Total assets were $41.8 million, total liabilities $8.6 million, and stockholders' equity $33.2 million. The company reported an accumulated deficit of $212.0 million and maintains a full valuation allowance on its deferred tax assets. Management describes ongoing commercialization efforts for VirnetX One™, War Room™, and VirnetX Matrix™, a CRADA with AFRL through 2030, and investments in AI/ML partnerships to support DoD-focused product adoption.